Track UiPath Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

UiPath Inc. PATH · Stock Open UiPath Inc. in new tab

13.94 USD
P/E
20.46
EPS
0.67
P/B
3.67
ROE
20.03
Beta
1.01
Target Price
15.50 USD
UiPath Inc. logo

UiPath Inc.

🧾 Earnings Recap – Q2 2027

UiPath’s shares fell 15.6% after earnings, indicating investors were disappointed by the still-moderate 12% ARR growth and concerns that the company’s growth reacceleration remains insufficient despite solid profitability and management’s claims of beating guidance. The quarter showed improving margins and AI adoption, but the market appears focused on the pace and durability of top-line expansion.

  • ARR reached $1.938 billion, up 12% year over year, including $37 million of net new ARR; revenue was $410 million, up 13%.
  • Non-GAAP operating income was $89 million, a 22% margin, expanding more than 400 basis points year over year; the company also reported its fourth consecutive quarter of GAAP profitability.
  • AI was present in 18 of the 20 largest deals, with customers expanding from individual automation use cases toward broader end-to-end workflows involving agents, robots, and orchestration.
  • Management cited larger AI-attached expansions, including a seven-figure expansion with a global insurance provider.
  • Ashim Gupta will become COO and Hitesh Ramani will succeed him as CFO, with management characterizing the transition as planned and providing continuity.
📅
Loading chart...
Key Metrics
Earnings dateDec. 2, 2026
P/E20.46
EPS0.67
Book Value3.74
Price to Book3.67
Debt/Equity4.09
% Insiders10.723%
Growth
Revenue Growth0.13%
Earnings Growth22.81%
Estimates
Forward P/E14.89
Forward EPS0.92
Target Mean Price15.50

DCF valuation

Model fair value for UiPath Inc. (PATH)
Result
Sign in to run the valuation for PATH.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
17 analysts · consensus None · mean target 15.50 USD (low 10.00, high 23.00) · as of 16 Oct 2026
Low 10.00
Mean 15.50
High 23.00
Price 13.94
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

UiPath Inc. Logo UiPath Inc. Analysis (PATH)

United States Information Technology Official Website Stock

Is UiPath Inc. a good investment? UiPath Inc. (PATH) is currently trading at 13.94 USD. Market analysts have a consensus price target of 15.50 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 20.46. This valuation is generally in line with the broader market.

Earnings Schedule: UiPath Inc. is expected to release its next earnings report on Dec. 2, 2026. The market consensus estimate for Forward EPS is 0.92.

Investor FAQ

Does UiPath Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is UiPath Inc.?

UiPath Inc. is classified as a Stock. You can compare it against 6 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Dec. 2, 2026. The company currently has a trailing EPS of 0.67.

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.

Exchange Ticker
BER (Germany) 9UV.BE
US90364P1057
FRA (Germany) 9UV.F
MUN (Germany) 9UV.MU
DUS (Germany) 9UV.DU
NYQ (United States) PATH
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion